Article · Volume 7, Issue 3 · pp. 120–121
What failed BIA 10–2474 Phase I clinical trial? Global speculations and recommendations for future Phase I trials
Rimplejeet Kaur1, Preeti Sidhu1, Surjit Singh1
Abstract
It is now known through the various studies that the endocannabinoids have dual role in human health. On the one hand, they contribute to the etiology of some diseases; on other they play “protective role” in some other disease states. This evoked the interest in developing exogenous drugs that can modulate cannabinoid system.
Keywords: Commentary
The full text of this article is available as a PDF. Open the PDF.